XML 20 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT
12 Months Ended
Dec. 31, 2011
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT [Abstract]  
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
SCHEDULE II
 
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
        
Form 10-K
 
        
Baldwin & Lyons, Inc.
 
(Dollars in thousands)
 
        
Condensed Balance Sheets
      
   
December 31
 
   
2011
  
2010
 
Assets
      
Investment in subsidiaries
 $334,328  $386,433 
Due from affiliates
  5,282   3,866 
Investments other than subsidiaries:
        
   Fixed maturities
  11,353   11,265 
   Limited partnerships
  291   704 
    11,644   11,969 
Cash and cash equivalents
  5,690   12,546 
Accounts receivable
  5,890   5,986 
Notes receivable from employees
  1,302   1,414 
Other assets
  6,392   5,747 
Total assets
 $370,528  $427,961 
Liabilities and shareholders' equity
        
          
Liabilities:
        
   Premiums payable
 $26,367  $27,147 
   Deposits from insureds
  13,682   15,196 
   Notes payable to bank
  10,000   15,000 
   Current payable federal income taxes
  368   335 
   Other liabilities
  1,050   1,548 
    51,467   59,226 
Shareholders' equity:
        
   Common stock:
        
      Class A
  112   112 
      Class B
  522   520 
      Additional paid-in capital
  48,751   47,874 
      Unrealized net gains on investments
  26,592   33,894 
      Retained earnings
  243,084   286,335 
    319,061   368,735 
          
Total liabilities and shareholders' equity
 $370,528  $427,961 
          
          
          
          
See notes to condensed financial statements
        

 
 
SCHEDULE II
 
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
           
Form 10-K
 
           
Baldwin & Lyons, Inc.
 
(Dollars in thousands)
 
           
Condensed Statements of Operations
         
   
Year Ended December 31
 
   
2011
  
2010
  
2009
 
Revenue:
         
   Commissions and service fees
 $20,974  $21,913  $19,182 
   Dividends from subsidiaries
  14,000   15,000   15,000 
   Net investment income
  100   135   506 
   Net realized gains (losses) on investments
  67   (100)  37 
   Other
  98   284   92 
    35,239   37,232   34,817 
Expenses:
            
   Salary and related items
  12,281   12,869   14,145 
   Other
  5,550   5,615   5,274 
    17,831   18,484   19,419 
Income before federal income taxes
            
and equity in undistributed
            
income of subsidiaries
  17,408   18,748   15,398 
Federal income tax (benefit)
  1,004   1,195   (496)
    16,404   17,553   15,894 
Equity in undistributed income (loss)
            
   of subsidiaries
  (44,579)  7,462   28,908 
              
Net income (loss)
 $(28,175) $25,015  $44,802 
              
              
              
              
              
              
See notes to condensed financial statements
            
 
 
 
SCHEDULE II
 
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
           
Form 10-K
 
           
Baldwin & Lyons, Inc.
 
(Dollars in thousands)
 
           
Condensed Statements of Cash Flows
         
   
Year Ended December 31
 
   
2011
  
2010
  
2009
 
           
Net cash provided by operating activities
 $13,255  $32,296  $18,309 
              
Investing activities:
            
   Purchases of long-term investments
  (10,025)  (10,889)  (6,803)
   Sales or maturities of long-term investments
  9,704   9,910   7,343 
   Decrease in notes receivable from employees
  106   611   143 
   Distributions from limited partnerships
  444   23   23 
   Net disposals (purchases) of property and equipment
  (622)  413   (2,124)
   Other
  128   212   188 
Net cash provided by (used in) investing activities
  (265)  280   (1,230)
              
Financing activities:
            
   Dividends paid to shareholders
  (14,846)  (33,212)  (14,744)
   Drawing on line of credit
  -   8,000   11,000 
   Repayment on line of credit
  (5,000)  (3,000)  (10,000)
   Cost of treasury shares
  -   -   (880)
Net cash used in financing activities
  (19,846)  (28,212)  (14,624)
Increase (decrease) in cash and cash equivalents
  (6,856)  4,364   2,455 
Cash and cash equivalents at beginning of year
  12,546   8,182   5,727 
Cash and cash equivalents at end of year
 $5,690  $12,546  $8,182 
              
              
See notes to condensed financial statements
            
              

 
Note to Condensed Financial Statements--Basis of Presentation
The Company's investment in subsidiaries is stated at cost plus equity in the undistributed earnings of subsidiaries since the date of acquisition.  The Company's share of net income of its subsidiaries is included in income using the equity method.  These financial statements should be read in conjunction with the Company's consolidated financial statements.